Hengjun He - Concepedia

Author

Hengjun He

Virginia Commonwealth University

Also Known As

Hengjun He

Publications

531

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University

About

Hengjun He is an author at Virginia Commonwealth University specializing in medicine, drug discovery, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	209
2	Pharmacology	3	3	82
3	Biochemistry	2	2	61
4	Cell Biology	1	1	127
5	Behavioral Pharmacology	1	1	36

Hengjun He

Publications

400

Citations

H-Index

Page 1

	Year	Citations
Arsenite induces HIF-1α and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells Ning Gao, Liqin Shen, Zhuo Zhang, Molecular and Cellular Biochemistry Tumor BiologyUrologyReactive Oxygen SpeciesMedicineCancer Cell Biology	2003	127
CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a Jason L. Niehaus, Yunguang Liu, Kathleen Wallis, Molecular Pharmacology	2007	121
Sphingosine and Its Analog, the Immunosuppressant 2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, Interact with the CB1 Cannabinoid Receptor Steven W. Paugh, Michael P. Cassidy, Hengjun He, Molecular Pharmacology	2006	70
Characterization of 6α- and 6β-<i>N</i>-Heterocyclic Substituted Naltrexamine Derivatives as Novel Leads to Development of Mu Opioid Receptor Selective Antagonists Yunyun Yuan, Li Guo, Hengjun He, ACS Chemical Neuroscience Molecular PharmacologyBiochemistryMu Opioid ReceptorMedicineFunctional Selectivity	2011	36
Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: Application of the ‘message–address’ concept in development of mu opioid receptor selective antagonists Saheem A. Zaidi, Christopher K. Arnatt, Hengjun He, Bioorganic & Medicinal Chemistry Molecular PharmacologyDrug TargetBiochemistryMode CharacterizationMedicine	2013	25
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies Li Guo, Lindsey C. Aschenbach, Hengjun He, Bioorganic & Medicinal Chemistry Letters 14-O-heterocyclic-substituted Naltrexone DerivativesMolecular PharmacologyMedicineMechanism Of ActionPharmacological Agent	2008	21

Page 1